|
Director since April 2007 Dr. Gemayel serves as Executive Vice President Therapeutics of Genzyme Corporation. Dr. Gemayel joined Genzyme in 2003 where he is responsible for the company’s therapeutics transplant renal and biosurgery businesses. Before he joined Genzyme Dr. Gemayel worked for the health care company Hoffman-LaRoche for 16 years. There he served as vice president of the U.S. Specialty Care Business with responsibilities for oncology transplantation hepatitis HIV and dermatology. He also was the general manager of Hoffman-LaRoche Portugal. Dr. Gemayel completed his doctorate in pharmacy at St. Joseph University in Beirut and earned a Ph.D. in pharmacology at Paris-Sud University. | 